SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-007255
Filing Date
2021-02-23
Accepted
2021-02-22 20:05:39
Documents
5
Period of Report
2021-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K 2021 STOCKHOLDERS MEETING snss-8k_20210222.htm 8-K 62605
2 GRAPHIC g0qslwbnmodr000004.jpg GRAPHIC 1113
3 GRAPHIC g0qslwbnmodr000003.jpg GRAPHIC 1113
4 GRAPHIC g0qslwbnmodr000001.jpg GRAPHIC 1113
5 GRAPHIC g0qslwbnmodr000002.jpg GRAPHIC 1113
  Complete submission text file 0001564590-21-007255.txt   70744
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 21662533
SIC: 2834 Pharmaceutical Preparations